Scholars@Duke publication: Control of lymphoproliferative and autoimmune disease in MRL-lpr/lpr mice by brequinar sodium: Mechanisms of action

Control of lymphoproliferative and autoimmune disease in MRL-lpr/lpr mice by brequinar sodium: Mechanisms of action

Publication , Journal Article

Xu, XL; Gong, HH; Blinder, L; Shen, JK; Williams, JW; Chong, ASF

Published in: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

1997

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

0022-3565

1997

283

869 / 875

APA

Chicago

ICMJE

MLA

NLM

Xu, X. L., Gong, H. H., Blinder, L., Shen, J. K., Williams, J. W., & Chong, A. S. F. (1997). Control of lymphoproliferative and autoimmune disease in MRL-lpr/lpr mice by brequinar sodium: Mechanisms of action. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 283(2), 869–875.

Xu, X. L., H. H. Gong, L. Blinder, J. K. Shen, J. W. Williams, and A. S. F. Chong. “Control of lymphoproliferative and autoimmune disease in MRL-lpr/lpr mice by brequinar sodium: Mechanisms of action.” JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 283, no. 2 (1997): 869–75.

Xu XL, Gong HH, Blinder L, Shen JK, Williams JW, Chong ASF. Control of lymphoproliferative and autoimmune disease in MRL-lpr/lpr mice by brequinar sodium: Mechanisms of action. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 1997;283(2):869–75.

Xu, X. L., et al. “Control of lymphoproliferative and autoimmune disease in MRL-lpr/lpr mice by brequinar sodium: Mechanisms of action.” JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, vol. 283, no. 2, 1997, pp. 869–75.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

0022-3565

1997

283

869 / 875